Mon, December 10, 2018
Fri, December 7, 2018
Thu, December 6, 2018

Joel Beatty Maintained (VNDA) at Strong Buy with Increased Target to $47 on, Dec 7th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. with-increased-target-to-47-on-dec-7th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Joel Beatty of Citigroup, Maintained "Vanda Pharmaceuticals Inc." (VNDA) at Strong Buy with Increased Target from $31 to $47 on, Dec 7th, 2018.

Joel has made no other calls on VNDA in the last 4 months.



There are 3 other peers that have a rating on VNDA. Out of the 3 peers that are also analyzing VNDA, 0 agree with Joel's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Joel


  • Charles Duncan of "Cantor Fitzgerald" Upgraded from Hold to Buy and Held Target at $43 on, Tuesday, December 4th, 2018
  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $26 on, Thursday, November 8th, 2018
  • Derek Archila of "Oppenheimer" Maintained at Buy with Increased Target to $29 on, Friday, September 21st, 2018